Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1285900

Cover Image

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1285900

U.S. Pruritus Treatment Market (Pruritus Type: Systemic Diseases, Skin Diseases, Neurologic Diseases, Nocturnal Pruritus, Pruritus Ani, and Others) - Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

PUBLISHED:
PAGES: 132 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 5795
PDF (Multi-user License)
USD 8795
PDF (Corporate License)
USD 11795

Add to Cart

U.S. Pruritus Treatment Market - Scope of Report

TMR's report on the U.S. Pruritus Treatment Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the U.S. Pruritus Treatment Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the U.S. Pruritus Treatment Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the U.S. Pruritus Treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global U.S. Pruritus Treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global U.S. Pruritus Treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global U.S. Pruritus Treatment market.

The report delves into the competitive landscape of the global U.S. Pruritus Treatment market. Key players operating in the U.S. Pruritus Treatment Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the U.S. Pruritus Treatment Market profiled in this report.

Key Questions Answered in U.S. Pruritus Treatment Market Report:

  • What is the sales/revenue generated by U.S. Pruritus Treatment across all regions during the forecast period?
  • What are the opportunities in the global U.S. Pruritus Treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

U.S. Pruritus Treatment Market - Research Objectives and Research Approach

The comprehensive report on the U.S. Pruritus Treatment Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the U.S. Pruritus Treatment Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global U.S. Pruritus Treatment market.

Product Code: TMRGL85582

Table of Contents

1. Preface

  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: U.S. Pruritus Treatment Market

4. Market Overview

  • 4.1. Overview
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
  • 4.3. U.S. Pruritus Treatment Market Analysis and Forecast, 2017-2031
    • 4.3.1. Market Revenue Projections (US$ Mn)
    • 4.3.2. Market Volume Projections (Thousand Units)

5. Key Insights

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Disease Prevalence & Incidence Rate
  • 5.3. Pricing Analysis
  • 5.4. Overview and Application of OTC Products in Treatment of Pruritus
  • 5.5. COVID-19 Impact Analysis

6. U.S. Pruritus Treatment Market Analysis and Forecast, by Pruritus Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Pruritus Type, 2017-2031
    • 6.3.1. Systemic Diseases
      • 6.3.1.1. Cancer
      • 6.3.1.2. Liver Disease
      • 6.3.1.3. Kidney Disease
      • 6.3.1.4. Others
    • 6.3.2. Skin Diseases
      • 6.3.2.1. Eczema
      • 6.3.2.2. Atopic Dermatitis
      • 6.3.2.3. Others
    • 6.3.3. Neurologic Diseases
      • 6.3.3.1. Shingles
      • 6.3.3.2. Multiple Sclerosis
      • 6.3.3.3. Others
    • 6.3.4. Nocturnal Pruritus
    • 6.3.5. Pruritus Ani
    • 6.3.6. Others
  • 6.4. Market Attractiveness Analysis, by Pruritus Type

7. U.S. Pruritus Treatment Market Analysis and Forecast, by Drug Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value & Volume Forecast, by Drug Type, 2017-2031
    • 7.3.1. Antihistamines
    • 7.3.2. Calcineurin Inhibitors
    • 7.3.3. Selective Serotonin Reuptake Inhibitors
    • 7.3.4. Corticosteroids
    • 7.3.5. Calamine
    • 7.3.6. Neuroleptics
    • 7.3.7. Others
  • 7.4. Market Attractiveness Analysis, by Drug Type

8. U.S. Pruritus Treatment Market Analysis and Forecast, by Sales Type

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value & Volume Forecast, by Sales Type, 2017 - 2031
    • 8.3.1. Rx Sales
    • 8.3.2. OTC Sales
  • 8.4. Market Attractiveness Analysis, by Sales Type

9. U.S. Pruritus Treatment Market Analysis and Forecast, by Dosage Form

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value & Volume Forecast, by Dosage Form, 2017-2031
    • 9.3.1. Topical
    • 9.3.2. Oral
  • 9.4. Market Attractiveness Analysis, by Dosages Form

10. U.S. Pruritus Treatment Market Analysis and Forecast, by Distribution Channel

  • 10.1. Introduction & Definition
  • 10.2. Key Findings/Developments
  • 10.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. Online Pharmacies
  • 10.4. Market Attractiveness Analysis, by Distribution Channel

11. Competition Landscape

  • 11.1. Market Player - Competition Matrix (by tier and size of companies)
  • 11.2. Market Share Analysis, by Company, 2021
  • 11.3. Company Profiles
    • 11.3.1. AbbVie, Inc. (Allergan plc)
      • 11.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 11.3.1.2. Test Type Portfolio
      • 11.3.1.3. Financial Overview
      • 11.3.1.4. SWOT Analysis
      • 11.3.1.5. Strategic Overview
    • 11.3.2. Albireo Pharma, Inc.
      • 11.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 11.3.2.2. Test Type Portfolio
      • 11.3.2.3. Financial Overview
      • 11.3.2.4. SWOT Analysis
      • 11.3.2.5. Strategic Overview
    • 11.3.3. Astellas Pharma, Inc.
      • 11.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 11.3.3.2. Test Type Portfolio
      • 11.3.3.3. Financial Overview
      • 11.3.3.4. SWOT Analysis
      • 11.3.3.5. Strategic Overview
    • 11.3.4. Cipla Limited
      • 11.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 11.3.4.2. Test Type Portfolio
      • 11.3.4.3. Financial Overview
      • 11.3.4.4. SWOT Analysis
      • 11.3.4.5. Strategic Overview
    • 11.3.5. Eli Lilly and Company
      • 11.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 11.3.5.2. Test Type Portfolio
      • 11.3.5.3. Financial Overview
      • 11.3.5.4. SWOT Analysis
      • 11.3.5.5. Strategic Overview
    • 11.3.6. GSK plc
      • 11.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 11.3.6.2. Test Type Portfolio
      • 11.3.6.3. Financial Overview
      • 11.3.6.4. SWOT Analysis
      • 11.3.6.5. Strategic Overview
    • 11.3.7. Merck & Co., Inc.
      • 11.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 11.3.7.2. Test Type Portfolio
      • 11.3.7.3. Financial Overview
      • 11.3.7.4. SWOT Analysis
      • 11.3.7.5. Strategic Overview
    • 11.3.8. Pfizer, Inc.
      • 11.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 11.3.8.2. Test Type Portfolio
      • 11.3.8.3. Financial Overview
      • 11.3.8.4. SWOT Analysis
      • 11.3.8.5. Strategic Overview
    • 11.3.9. Teva Pharmaceutical Industries Ltd.
      • 11.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 11.3.9.2. Test Type Portfolio
      • 11.3.9.3. Financial Overview
      • 11.3.9.4. SWOT Analysis
      • 11.3.9.5. Strategic Overview
    • 11.3.10. Viatris Inc. (Mylan N.V.)
      • 11.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 11.3.10.2. Test Type Portfolio
      • 11.3.10.3. Financial Overview
      • 11.3.10.4. SWOT Analysis
      • 11.3.10.5. Strategic Overview
Product Code: TMRGL85582

List of Tables

  • Table 01: U.S. Pruritus Treatment Market Value (US$ Mn) Forecast, by Pruritus Type, 2017-2031
  • Table 02: U.S. Pruritus Treatment Market Value (US$ Mn) Forecast, by Systemic Diseases, 2017-2031
  • Table 03: U.S. Pruritus Treatment Market Value (US$ Mn) Forecast, by Skin Diseases, 2017-2031
  • Table 04: U.S. Pruritus Treatment Market Value (US$ Mn) Forecast, by Neurologic Diseases, 2017-2031
  • Table 05: U.S. Pruritus Treatment Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
  • Table 06: U.S. Pruritus Treatment Market Volume (Thousand Units) Forecast, by Drug Type, 2017-2031
  • Table 07: U.S. Pruritus Treatment Market Value (US$ Mn) Forecast, by Sales Type, 2017-2031
  • Table 08: U.S. Pruritus Treatment Market Volume (Thousand Units) Forecast, by Sales Type, 2017-2031
  • Table 09: U.S. Pruritus Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 10: U.S. Pruritus Treatment Market Volume (Thousand Units) Forecast, by Dosage Form, 2017-2031
  • Table 11: U.S. Pruritus Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: U.S. Pruritus Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: U.S. Pruritus Treatment Market Volume (Thousand Units) Forecast, 2017-2031
  • Figure 03: U.S. Pruritus Treatment Market Value Share, by Pruritus Type, 2022
  • Figure 04: U.S. Pruritus Treatment Market Value Share, by Drug Type, 2022
  • Figure 05: U.S. Pruritus Treatment Market Value Share, by Sales Type, 2022
  • Figure 06: U.S. Pruritus Treatment Market Value Share, by Dosage Form, 2022
  • Figure 07: U.S. Pruritus Treatment Market Value Share, by Distribution Channel, 2022
  • Figure 08: U.S. Pruritus Treatment Market Value Share Analysis, by Pruritus Type, 2022 and 2031
  • Figure 09: U.S. Pruritus Treatment Market Attractiveness Analysis, by Pruritus Type, 2023-2031
  • Figure 10: U.S. Pruritus Treatment Market (US$ Mn), by Systemic Diseases, 2017-2031
  • Figure 11: U.S. Pruritus Treatment Market (US$ Mn), by Skin Diseases, 2017-2031
  • Figure 12: U.S. Pruritus Treatment Market (US$ Mn), by Neurologic Diseases, 2017-2031
  • Figure 13: U.S. Pruritus Treatment Market (US$ Mn), by Nocturnal Pruritus, 2017-2031
  • Figure 14: U.S. Pruritus Treatment Market (US$ Mn), by Pruritus Ani, 2017-2031
  • Figure 15: U.S. Pruritus Treatment Market (US$ Mn), by Nocturnal Pruritus, 2017-2031
  • Figure 16: U.S. Pruritus Treatment Market Value Share Analysis, by Drug Type, 2022 and 2031
  • Figure 17: U.S. Pruritus Treatment Market Attractiveness Analysis, by Drug Type, 2023-2031
  • Figure 18: U.S. Pruritus Treatment Market (US$ Mn), by Antihistamines, 2017-2031
  • Figure 19: U.S. Pruritus Treatment Market (US$ Mn), by Calcineurin Inhibitors, 2017-2031
  • Figure 20: U.S. Pruritus Treatment Market (US$ Mn), by Selective Serotonin Reuptake Inhibitors, 2017-2031
  • Figure 21: U.S. Pruritus Treatment Market (US$ Mn), by Corticosteroids, 2017-2031
  • Figure 22: U.S. Pruritus Treatment Market (US$ Mn), by Calamine, 2017-2031
  • Figure 23: U.S. Pruritus Treatment Market (US$ Mn), by Corticosteroids, 2017-2031
  • Figure 24: U.S. Pruritus Treatment Market (US$ Mn), by Others, 2017-2031
  • Figure 25: U.S. Pruritus Treatment Market Value Share Analysis, by Sales Type, 2022 and 2031
  • Figure 26: U.S. Pruritus Treatment Market Attractiveness Analysis, by Sales Type, 2023-2031
  • Figure 27: U.S. Pruritus Treatment Market (US$ Mn), by Rx Sales, 2017-2031
  • Figure 28: U.S. Pruritus Treatment Market (US$ Mn), by OTC Sales, 2017-2031
  • Figure 29: U.S. Pruritus Treatment Market Value Share Analysis, by Dosage Form, 2022 and 2031
  • Figure 30: U.S. Pruritus Treatment Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 31: U.S. Pruritus Treatment Market (US$ Mn), by Topical, 2017-2031
  • Figure 32: U.S. Pruritus Treatment Market (US$ Mn), by Oral, 2017-2031
  • Figure 33: U.S. Pruritus Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 34: U.S. Pruritus Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 35: U.S. Pruritus Treatment Market (US$ Mn), by Hospital Pharmacies, 2017-2031
  • Figure 36: U.S. Pruritus Treatment Market (US$ Mn), by Retail Pharmacies, 2017-2031
  • Figure 37: U.S. Pruritus Treatment Market (US$ Mn), by Online Pharmacies, 2017-2031
  • Figure 38: U.S. Pruritus Treatment Market Share Analysis, by Company, 2022
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!